Atara Biotherapeutics’ Executive Turnover and Workforce Cuts Elevate Execution Risk and Threaten Strategic ProgressTip Ranks·Aug 14 at 06:01 AMATRA-3.26%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jul 20 at 12:05 PMBRNS-6.61%VBIO+18.09%
Atara Biotherapeutics files initial beneficial ownership statement for interim CFO Kevin SarneyPUBT·Jul 6 at 08:15 PMATRA-3.26%
Mizuho Securities Sticks to Their Buy Rating for Atara Biotherapeutics (ATRA)Tip Ranks·Jun 21 at 08:16 AMATRA-3.26%
09:00 ETThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRAprnewswire·May 26 at 01:01 PMATRA-3.26%IBBQ+0.01%
ATRA Deadline: Rosen Law Firm Urges Atara Biotherapeutics, Inc. (NASDAQ: ATRA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their RightsMorningStar·May 22 at 07:00 PMATRA-3.26%IBB+0.05%
ATRA FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026MorningStar·May 22 at 01:35 PMATRA-3.26%XBI+0.07%
09:01 ETATRA EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026prnewswire·May 21 at 01:02 PMATRA-3.26%FBT+0.07%
